Wednesday, March 29, 2023
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Health Sciences Clinical Professor of Family Medicine, University of California, Irvine, California
This article is intended for primary care physicians, obstetrician gynecologists, endocrinologists, nurses, pharmacists, and other physicians who care for women with polycystic ovary syndrome (PCOS).
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Health Sciences Clinical Professor of Family Medicine, University of California, Irvine, California
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number JA0007105-0000-18-191-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 9/12/2018
Valid for credit through: 9/12/2019
processing....
Polycystic ovary syndrome is a disease state that might promote reduced QoL across several different health domains. Which of these domains is most important to women with PCOS? A previous study by Bazarganipour and colleagues addressed this issue. They reported their results in the April 2014 issue of the Journal of Sexual Medicine.[1]
Researchers performed a battery of tests regarding physical and psychological symptoms as well as assessments of health-related quality of life (HRQoL) among 300 women with PCOS. All study participants lived in Iran.
Women reported that the reproductive and menstrual effects of PCOS were the most dominant predictors of severity of disease, and they also had a significant effect on overall HRQoL. Self-esteem, body image, and sexual function (especially desire and arousal) were domains of HRQoL particularly affected by PCOS.
Patients with PCOS should receive empathic, supportive care that speaks to the physical, emotional, and social effects of illness. The current study by Lin and colleagues evaluates whether physicians are providing this type of care to women with PCOS in the United States.
In a newly published survey, women with PCOS have expressed a heightened distrust in the opinions of primary care physicians (PCPs) -- but not specialists -- of their PCOS condition. The respondents also questioned the ability of general practitioners to address the social burdens of PCOS, underscoring the need for improved efforts to manage patients' concerns at the primary care level.
The research was published August 1 in the Journal of the Endocrine Society by Annie W. Lin, PhD, RD, Cornell University, Ithaca, New York, and colleagues.[2]
"Our study suggests that physicians can improve the patient–provider relationship by tailoring their advice to acknowledge the broad impact that PCOS has on women's lives, and to listen to patient concerns without judgment. These efforts can potentially bring about continuity of care for women with PCOS," said senior author Marla E. Lujan, PhD, also of Cornell University, in a statement by the Endocrine Society.
The researchers surveyed 332 women, including 134 with PCOS and 198 with regular menses at mean age of 27.8±5.2 years, to compare their impressions of their physicians and the general care the physicians provided.
The results showed that women with PCOS had significantly greater distrust of the PCPs' opinions compared with women with regular menses (P <.01).
Furthermore, patients with PCOS expressed the view that PCPs were not as well qualified to treat PCOS, compared with treatment of general health issues (P <.001).
Meanwhile, having PCOS was not associated with lower trust in specialists such as endocrinologists.
Polycystic ovary syndrome affects 7% to 10% of women of reproductive age, making it the most common cause of infertility. The disorder can cause distressing symptoms such as irregular periods, weight gain, many small ovarian cysts, and excess hair, and it has been linked to other health conditions such as mental health disorders, type 2 diabetes, obesity, and heart disease.
In the survey, patients with PCOS indicated their healthcare providers (HCPs) were more inclined to argue with them about health-related issues vs the comparison group (P =.02).
Additionally, although participants reported rarely having negative encounters with their HCPs, the women with PCOS said they only sometimes were satisfied with the emotional support they received in their health care.
The women surveyed were enrolled in a larger observational study and completed a 28-item Web-based survey, called the Instrument for Polycystic Ovary Syndrome: Medical Experiences (I-PCOSM), that assessed their experiences over the past 3 years.
The authors speculated that differences in patients' perceptions of PCPs and specialists could largely relate to the different roles each have in patient management.
"We hypothesize that PCPs face greater feelings of distrust because they are at the frontline of healthcare delivery and frequently provide referrals when encountering medical conditions outside their usual scope of practice."
Backing the findings, other research has shed light on the inconsistent care patients with PCOS may receive, including a study by Dokras and colleagues that showed knowledge levels of PCOS varies between reproductive endocrinologists and gynecologists[3] and another study by Gibson-Helm and colleagues that revealed a substantial lag period between symptom onset and diagnosis of PCOS by multiple HCPs.[4]
In the latter study, women with PCOS commonly failed to receive information about PCOS and the dietary and physical activity behaviors that can benefit the condition. That study also showed many women with PCOS consulted 3 or more HCPs and waited more than 2 years to be correctly diagnosed.
The new study is believed to be the first of its kind to directly explore PCOS patients' perceptions of the issues of trust and belief in their HCPs' provision of social support, and the findings suggest the need for a more attentive approach to PCOS, the authors reiterated.
"When interacting with a patient... we suggest that physicians consider tailoring their advice to acknowledge the unique challenges and concerns of women living with PCOS and listen to the patients without judgment," the authors suggested. "Providing strong informational and emotional support may help reduce feelings of distrust between patients and physicians.
"We also recommend the importance of strengthening the specialty-referral process and identifying patient cues for when a referral may be the optimal approach when diagnosing and/or treating women at risk for PCOS," they concluded.
The study received partial support from Cornell University grants from the Human Ecology Alumni Association and College of Agriculture and Life Sciences Alumni Association. The authors have reported no relevant financial relationships.
J Endocr Soc. 2018;2:1001-1009.
